Literature DB >> 11603922

Protein kinase C(epsilon) modulates apoptosis induced by beta -adrenergic stimulation in adult rat ventricular myocytes via extracellular signal-regulated kinase (ERK) activity.

Y Shizukuda1, P M Buttrick.   

Abstract

Beta-adrenergic stimulation of ventricular myocytes has been shown to induce apoptosis; however, the cellular mechanisms involved in this pathway have not been completely characterized. This study examines the role of protein kinase C (PKC) in the signaling cascade that mediates beta-adrenergic stimulation-induced apoptosis. Stimulation of beta-adrenergic receptors using isoproterenol (ISO, 1-10 microm, 24 h) induced apoptosis in cultured adult rat ventricular myocytes (ARVM) in a dose-dependent manner. Treatment with ISO significantly resulted in the membrane translocation of PKC(epsilon), but not of PKC alpha or delta in ARVM. The activation of PKC(epsilon) by ISO was confirmed using an immune complex kinase assay. To address whether PKC(epsilon) is involved in the mechanism of ISO-induced apoptosis, we used the PKC(epsilon)-specific translocation inhibitor peptide, epsilonV1-2. Peptide epsilonV1-2 significantly blocked the translocation of PKC(epsilon), as well as the enzymatic action of PKC(epsilon), resulting from ISO stimulation. The inhibition of PKC(epsilon) attenuated ISO-induced apoptosis as measured by terminal deoxynucleotidyltransferase nick-end labeling (TUNEL) assay (18.2+/-3.8%v 49.0+/-2.4%P<0.05), while a PKC delta-specific peptide translocation inhibitor (delta V1-1) failed to do so (39.8+/-7.8%). In the presence of ISO, PKC(epsilon) inhibition by epsilonV1-2 was found to significantly enhance activity of ERK, but not that of Akt/PKB. Inhibition of ERK activation by PD 98059 (10-50 microm) attenuated the epsilonV1-2 peptide-mediated anti-apoptotic effect, thus suggesting that ERK activation is involved in this anti-apoptotic effect. Therefore, our results suggest that activation of PKC(epsilon) downstream of beta-adrenergic stimulation promotes apoptosis largely via inhibition of an ERK activation-dependent anti-apoptotic effect. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11603922     DOI: 10.1006/jmcc.2001.1442

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  10 in total

Review 1.  βIIPKC and εPKC isozymes as potential pharmacological targets in cardiac hypertrophy and heart failure.

Authors:  Julio Cesar Batista Ferreira; Patricia Chakur Brum; Daria Mochly-Rosen
Journal:  J Mol Cell Cardiol       Date:  2010-10-28       Impact factor: 5.000

2.  Factors released from embryonic stem cells inhibit apoptosis in H9c2 cells through PI3K/Akt but not ERK pathway.

Authors:  Dinender K Singla; Reetu D Singla; Debbie E McDonald
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-06-13       Impact factor: 4.733

3.  β-Adrenergic receptors stimulate interleukin-6 production through Epac-dependent activation of PKCδ/p38 MAPK signalling in neonatal mouse cardiac fibroblasts.

Authors:  Chao Chen; Jianhai Du; Wei Feng; Yao Song; Zhizhen Lu; Ming Xu; Zijian Li; Youyi Zhang
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

Review 4.  Metabolic dysfunction in diabetic cardiomyopathy.

Authors:  Michael Isfort; Sarah C W Stevens; Stephen Schaffer; Chian Ju Jong; Loren E Wold
Journal:  Heart Fail Rev       Date:  2014-01       Impact factor: 4.214

5.  Glucose phosphorylation and mitochondrial binding are required for the protective effects of hexokinases I and II.

Authors:  Lin Sun; Shetha Shukair; Tejaswitha Jairaj Naik; Farzad Moazed; Hossein Ardehali
Journal:  Mol Cell Biol       Date:  2007-11-26       Impact factor: 4.272

6.  Chelerythrine treatment influences the balance of pro- and anti-apoptotic signaling pathways in the remote myocardium after infarction.

Authors:  Gregor Simonis; Stephan Wiedemann; Kerstin Schwarz; Torsten Christ; Daniel G Sedding; Xinjian Yu; Rainer Marquetant; Ruediger C Braun-Dullaeus; Ursula Ravens; Ruth H Strasser
Journal:  Mol Cell Biochem       Date:  2007-12-02       Impact factor: 3.396

7.  Stimulation of adenosine A2b receptors blocks apoptosis in the non-infarcted myocardium even when administered after the onset of infarction.

Authors:  Gregor Simonis; Stephan Wiedemann; Dirk Joachim; Christof Weinbrenner; Rainer Marquetant; Ruth H Strasser
Journal:  Mol Cell Biochem       Date:  2009-03-20       Impact factor: 3.396

8.  Factors released from embryonic stem cells inhibit apoptosis of H9c2 cells.

Authors:  Dinender K Singla; Debbie E McDonald
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-06-01       Impact factor: 4.733

9.  Urotensin II inhibits doxorubicin-induced human umbilical vein endothelial cell death by modulating ATF expression and via the ERK and Akt pathway.

Authors:  Yen-Ling Chen; Yi-Ting Tsai; Chung-Yi Lee; Chien-Hsing Lee; Chung-Yi Chen; Chi-Ming Liu; Jin-Jer Chen; Shih-Hurng Loh; Chien-Sung Tsai
Journal:  PLoS One       Date:  2014-09-30       Impact factor: 3.240

Review 10.  Protein kinase C in heart failure: a therapeutic target?

Authors:  Suresh Selvaraj Palaniyandi; Lihan Sun; Julio Cesar Batista Ferreira; Daria Mochly-Rosen
Journal:  Cardiovasc Res       Date:  2009-01-24       Impact factor: 13.081

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.